Author

S. Meena

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Sinha· 2 shared A. Verma· 2 shared D. Datta· 2 shared K. K. Saini· 2 shared M. A. Khan· 2 shared M. A. Nengroo· 2 shared M. P. Singh· 2 shared S. R. Satrusal· 2 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Sinha

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ACSL4 activity drives TNBC metastasis by positively regulating Histone H3 Acetylation mediated SNAIL expression

A. Sinha, K. K. Saini, K. Tripathi, M. A. Khan, S. R. Satrusal, A. Verma, B. Mandal, P. Rai, S. Meena, M. A. Nengroo, M. P. Singh, N. S. Bhushan, M. Vasudevan, A. Singhai, K. Singh, , D. Datta

This study identifies ACSL4 as a driver of TNBC metastasis by enhancing histone acetylation and SNAIL expression through metabolic and epigenetic mechanisms.

bioRxiv · Oct 16, 2023 · PreprintCancer Biology

PERK arm of UPR selectively regulates ferroptosis in colon cancer cells by modulating the expression of SLC7A11 (System Xc-)

K. K. Saini, P. Chaturvedi, A. Sinha, M. P. Singh, M. A. Khan, A. Verma, M. A. Nengroo, S. R. Satrusal, S. Meena, A. Singh, S. Srivastava, J. Sarkar, D. Datta

This study shows that PERK inhibition reduces SLC7A11 expression and sensitizes colon cancer cells to ferroptosis, suggesting PERK inhibitors as potential therapeutics.

bioRxiv · Mar 28, 2023 · PreprintCancer Biology